Join
Live feed
·
PRReleasevia Quantisnow
Esperion Therapeutics Inc. logo

Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

ByQuantisnow·Wall Street's wire, on your screen.
ESPR· Esperion Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ESPR (Esperion Therapeutics Inc.) and more on Quantisnow.